MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

07 Aug 2025 Evaluate
The revenue zoomed 17.72% to Rs. 0.93 millions for the quarter ended June 2025 as compared to Rs. 0.79 millions during the corresponding quarter last year.Net profit surges 90.00% to Rs. 1.71  millions  from Rs. 0.90 millions in the quarter ended June 2025.OP of the company witnessed a marginal growth to 2.57 millions from 1.83 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.93 0.79 17.72 0.93 0.79 17.72 6.11 5.55 10.09
Other Income 5.34 4.57 16.85 5.34 4.57 16.85 20.09 19.92 0.85
PBIDT 2.57 1.83 40.44 2.57 1.83 40.44 10.58 9.10 16.26
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
PBDT 2.56 1.83 39.89 2.56 1.83 39.89 10.57 9.10 16.15
Depreciation 0.25 0.24 4.17 0.25 0.24 4.17 0.98 0.98 0.00
PBT 2.31 1.59 45.28 2.31 1.59 45.28 9.59 8.12 18.10
TAX 0.60 0.69 -13.04 0.60 0.69 -13.04 6.42 1.62 296.30
Deferred Tax 0.00 0.39 -100.00 0.00 0.39 -100.00 2.02 1.49 35.57
PAT 1.71 0.90 90.00 1.71 0.90 90.00 3.17 6.50 -51.23
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 276.34 231.65 19.30 276.34 231.65 19.30 173.16 163.96 5.61
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..